Gm2 Gangliosidoses Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Gm2 Gangliosidoses stocks.

Gm2 Gangliosidoses

Gm2 Gangliosidoses is a group of rare, inherited disorders caused by the buildup of a fatty substance called GM2 ganglioside in the body's cells. This buildup can cause a wide range of symptoms, including intellectual disability, seizures, movement problems, and vision and hearing loss. Treatment is supportive and may include physical, occupational, and speech therapy, as well as medications to control seizures.

Browse All Tags